Prognostic significance of melanogenesis pathway and its association with the ultrastructural characterisation of melanosomes in uveal melanoma.

Choroid Pathology

Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
21 Sep 2023
Historique:
received: 04 01 2023
accepted: 30 08 2023
medline: 22 9 2023
pubmed: 22 9 2023
entrez: 21 9 2023
Statut: aheadofprint

Résumé

Pigmentation could be a relevant prognostic factor in uveal melanoma (UM) development. Microphthalmia-associated transcription factor (MITF) regulates melanin synthesis by activating tyrosinase-related protein 2 (TYRP2) and silver protein (SILV) that induce the melanogenesis pathway. Although their oncogenic potential has been observed in various malignancies but has not been investigated in UM Asian population. Our aim is to study the ultrastructure of melanosomes and the prognostic significance of pigmentation markers such as TYRP2, MITF and SILV in UM. Transmission electron microscopy was performed to compare the ultrastructure of melanosomes in the normal choroid and UM cases. Immunoexpression of TYRP2, SILV and MITF was analysed in 82 UM samples. The mRNA expression level of all genes was measured in 70 UM cases. A statistical correlation was performed to determine the prognostic significance of all markers. Premelanosomes and mature melanosomes undergoing dedifferentiation were observed in high-pigmented UM cases as compared with low-pigmented UM cases. Seventy per cent of UM cases showed high SILV expression while TYRP2 and MITF expression was present in 58% and 56% of cases, respectively. At the mRNA level, upregulation of TYRP2, SILV and MITF markers was seen in around 50% of UM cases, which was statistically significant with high pigmentation. Reduced metastatic-free survival was statistically significant with the MITF protein expression. Our results demonstrated that ultrastructural changes in melanosomes and high expression of TYRP2, MITF and SILV could dysregulate the melanogenesis pathway and might be responsible for the aggressive behaviour of UM.

Sections du résumé

BACKGROUND BACKGROUND
Pigmentation could be a relevant prognostic factor in uveal melanoma (UM) development. Microphthalmia-associated transcription factor (MITF) regulates melanin synthesis by activating tyrosinase-related protein 2 (TYRP2) and silver protein (SILV) that induce the melanogenesis pathway. Although their oncogenic potential has been observed in various malignancies but has not been investigated in UM Asian population. Our aim is to study the ultrastructure of melanosomes and the prognostic significance of pigmentation markers such as TYRP2, MITF and SILV in UM.
METHODS METHODS
Transmission electron microscopy was performed to compare the ultrastructure of melanosomes in the normal choroid and UM cases. Immunoexpression of TYRP2, SILV and MITF was analysed in 82 UM samples. The mRNA expression level of all genes was measured in 70 UM cases. A statistical correlation was performed to determine the prognostic significance of all markers.
RESULTS RESULTS
Premelanosomes and mature melanosomes undergoing dedifferentiation were observed in high-pigmented UM cases as compared with low-pigmented UM cases. Seventy per cent of UM cases showed high SILV expression while TYRP2 and MITF expression was present in 58% and 56% of cases, respectively. At the mRNA level, upregulation of TYRP2, SILV and MITF markers was seen in around 50% of UM cases, which was statistically significant with high pigmentation. Reduced metastatic-free survival was statistically significant with the MITF protein expression.
CONCLUSION CONCLUSIONS
Our results demonstrated that ultrastructural changes in melanosomes and high expression of TYRP2, MITF and SILV could dysregulate the melanogenesis pathway and might be responsible for the aggressive behaviour of UM.

Identifiants

pubmed: 37734767
pii: bjo-2023-323181
doi: 10.1136/bjo-2023-323181
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Jayanti Jha (J)

Ocular Pathology, All India Institute of Medical Sciences, New Delhi, Delhi, India.

Mithalesh Kumar Singh (MK)

Ophthalmology, UT Southwestern Medical Center, Dallas, Texas, USA.

Lata Singh (L)

Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

Neelam Pushker (N)

Ophthalmology, All India Institute of Medical Sciences, New Delhi, Delhi, India.

Rachna Meel (R)

Ophthalmology, All India Institute of Medical Sciences, New Delhi, Delhi, India.

Neiwete Lomi (N)

Ophthalmology, All India Institute of Medical Sciences, New Delhi, Delhi, India.

Sameer Bakhshi (S)

Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.

Tapas Chandra Nag (TC)

Department of Anatomy, All India Institute of Medical Sciences, New Delhi, Delhi, India.

Kunzang Chosdol (K)

Biochemistry, All India Institute of Medical Sciences, New Delhi, Delhi, India.

Seema Sen (S)

Ocular Pathology, Dr.R.P. Centre, All India Institute of Medical Sciences, New Delhi, Delhi, India.

Seema Kashyap (S)

Ocular Pathology, All India Institute of Medical Sciences, New Delhi, Delhi, India seemakashyap65@gmail.com.

Classifications MeSH